Codexis Financials
| CDXS Stock | USD 2.58 0.19 6.86% |
Operating Margin | Profit Margin | Short Ratio 6.34 | EPS Estimate Current Year (0.56) | EPS Estimate Current Quarter (0.21) |
Investors should never underestimate Codexis' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Codexis' cash flow, debt, and profitability to make informed and accurate decisions about investing in Codexis.
Net Income |
|
Codexis | Select Account or Indicator | Build AI portfolio with Codexis Stock |
Understanding current and past Codexis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Codexis' financial statements are interrelated, with each one affecting the others. For example, an increase in Codexis' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Codexis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Codexis. Check Codexis' Beneish M Score to see the likelihood of Codexis' management manipulating its earnings.
Codexis Stock Summary
Codexis competes with Dine Brands, IAC, El Pollo, Coupang LLC, and CDW Corp. Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US1920051067 |
| CUSIP | 192005106 |
| Location | California; U.S.A |
| Business Address | 200 Penobscot Drive, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.codexis.com |
| Phone | 650 421 8100 |
| Currency | USD - US Dollar |
Codexis Key Financial Ratios
| Revenue | 59.34 M | ||||
| Gross Profit | (12.31 M) | ||||
| EBITDA | (58.52 M) | ||||
| Net Income | (65.28 M) | ||||
| Total Asset | 149.01 M |
Codexis Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 221.6M | 246.4M | 250.4M | 136.6M | 149.0M | 126.2M | |
| Other Current Liab | 14.9M | 19.6M | 21.4M | 16.0M | 12.4M | 13.5M | |
| Net Debt | (124.2M) | (69.1M) | (70.3M) | (49.1M) | 40.6M | 42.7M | |
| Retained Earnings | (366.4M) | (387.7M) | (421.3M) | (497.5M) | (562.8M) | (534.7M) | |
| Accounts Payable | 3.0M | 3.0M | 3.2M | 5.9M | 2.8M | 3.9M | |
| Cash | 149.1M | 116.8M | 114.0M | 65.1M | 19.3M | 18.3M | |
| Net Receivables | 29.3M | 37.7M | 40.9M | 19.9M | 18.9M | 16.1M | |
| Inventory | 964K | 1.2M | 2.0M | 2.7M | 1.8M | 1.4M | |
| Other Current Assets | 4.1M | 6.3M | 6.0M | 5.7M | 500K | 525K | |
| Total Liab | 51.5M | 82.0M | 105.6M | 49.9M | 82.1M | 50.3M | |
| Total Current Assets | 184.4M | 161.9M | 162.9M | 93.5M | 98.8M | 88.8M | |
| Short Term Debt | 5.3M | 8.2M | 10.7M | 3.8M | 5.7M | 4.0M | |
| Other Liab | 3.2M | 4.2M | 5.1M | 18.3M | 16.4M | 17.2M | |
| Other Assets | 1.2M | 1.4M | 1.8M | 1.9M | 1.7M | 1.6M | |
| Net Tangible Assets | 102.3M | 166.9M | 161.2M | 141.6M | 162.8M | 170.9M | |
| Capital Surpluse | 386.8M | 447.9M | 536.5M | 552.1M | 634.9M | 406.3M |
Codexis Key Income Statement Accounts
The reason investors look at the income statement is to determine what Codexis' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 4.8M | 7.6M | 1.4M | 10.4M | 12.0M | 12.5M | |
| Total Revenue | 69.1M | 104.8M | 138.6M | 70.1M | 59.3M | 73.5M | |
| Gross Profit | 55.3M | 82.5M | 100.6M | 57.3M | 43.1M | 54.6M | |
| Operating Income | (23.9M) | (22.7M) | (31.7M) | (68.1M) | (58.5M) | (55.6M) | |
| Ebit | (23.9M) | (22.7M) | (33.3M) | (59.2M) | (58.4M) | (55.4M) | |
| Research Development | 44.2M | 55.9M | 80.1M | 58.9M | 46.3M | 46.3M | |
| Ebitda | (19.4M) | (16.8M) | (23.1M) | (49.3M) | (58.5M) | (55.6M) | |
| Cost Of Revenue | 13.7M | 22.2M | 38.0M | 12.8M | 16.3M | 18.9M | |
| Income Before Tax | (23.7M) | (21.1M) | (33.3M) | (76.2M) | (65.2M) | (62.0M) | |
| Net Income | (24.0M) | (21.3M) | (33.6M) | (76.2M) | (65.3M) | (62.0M) | |
| Income Tax Expense | 339K | 189K | 276K | 69K | 34K | 57.9K | |
| Tax Provision | 339K | 189K | 276K | 185K | 34K | 32.3K | |
| Interest Income | 405K | 459K | 1.4M | 4.1M | 3.7M | 3.9M | |
| Net Interest Income | 405K | 459K | 1.4M | 4.1M | 3.7M | 3.9M |
Codexis Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (593K) | (196K) | (869K) | (656K) | 886K | 930.3K | |
| Change In Cash | 58.6M | (31.9M) | (2.9M) | (49.3M) | (45.9M) | (43.6M) | |
| Free Cash Flow | (20.2M) | (28.1M) | 3.0M | (57.1M) | (53.7M) | (51.0M) | |
| Depreciation | 4.6M | 5.9M | 10.3M | 9.9M | 4.9M | 6.8M | |
| Other Non Cash Items | 55K | (19K) | (1.5M) | 21.9M | 9.8M | 10.3M | |
| Capital Expenditures | 3.7M | 13.8M | 8.3M | 4.4M | 4.3M | 4.9M | |
| Net Income | (24.0M) | (21.3M) | (33.6M) | (76.2M) | (65.3M) | (62.0M) | |
| End Period Cash Flow | 150.8M | 118.9M | 116.0M | 66.7M | 20.8M | 19.8M | |
| Investments | (2M) | (7.6M) | (13.6M) | (5.9M) | (57.0M) | (54.1M) | |
| Change Receivables | 960K | 2.5M | (8.7M) | (9.2M) | (8.2M) | (7.8M) | |
| Change To Netincome | 7.5M | 7.8M | 8.7M | 13.1M | 15.0M | 8.3M |
Codexis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Codexis's current stock value. Our valuation model uses many indicators to compare Codexis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Codexis competition to find correlations between indicators driving Codexis's intrinsic value. More Info.Codexis is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Codexis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Codexis Systematic Risk
Codexis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Codexis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Codexis correlated with the market. If Beta is less than 0 Codexis generally moves in the opposite direction as compared to the market. If Codexis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Codexis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Codexis is generally in the same direction as the market. If Beta > 1 Codexis moves generally in the same direction as, but more than the movement of the benchmark.
Codexis Thematic Clasifications
Codexis is part of several thematic ideas from Synthetics to Chemicals Makers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasCodexis July 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Codexis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Codexis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Codexis based on widely used predictive technical indicators. In general, we focus on analyzing Codexis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Codexis's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.13 | |||
| Information Ratio | 0.0123 | |||
| Maximum Drawdown | 27.22 | |||
| Value At Risk | (6.99) | |||
| Potential Upside | 7.89 |
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.